Tag Archives: patients

Artificial intelligence can identify at-risk patients, inform care and improve disease prevention

There’s no shortage of buzz around artificial intelligence and its potential impact on a variety of areas within healthcare, from patient care to revenue cycle operations. There is an emerging trend toward AI assets that amplify the value of patient data and provide an extendable, scalable pathway to effective primary disease prevention. That’s something that… Read More »

FDA clears AI-based wearable device to monitor hospital patients

The Food and Drug Administration has approved a wireless device that continuously and automatically monitors patients using artificial intelligence to provide clinicians with actionable insights. Scottish company Current Health, the manufacturer of the wearable device, announced on Wednesday that it has received Class II clearance from the FDA for hospital care. Also See: FDA clears… Read More »

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

Print this page HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with obinutuzumab in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the most common form of leukemia in adults.1 This is… Read More »